• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1996 Fiscal Year Final Research Report Summary

Analysis of immunological reconstitution after allogeneic bone marrow transplantation

Research Project

Project/Area Number 06670778
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatrics
Research InstitutionYamanashi Medical University

Principal Investigator

SUGITA Kanji  Yamanashi Medical University, Pediatrics, Assistant, 医学部, 助手 (60138055)

Co-Investigator(Kenkyū-buntansha) GOI Kumiko  Yamanashi Medical University, Pediatrics, Staff, 医学部, 医員
IIJIMA Kiyomu  Yamanashi Medical University, Pediatrics, Staff, 医学部, 医員
SAITO Midori  Yamanashi Medical University, Pediatrics, Assistant, 医学部, 助手 (20170532)
Project Period (FY) 1994 – 1996
Keywordsallogeneic bone marrow transplantation / T cell dysfunction / CD28 / CD29 / CD29
Research Abstract

Although allogeneic bone marrow transplantation (allo-BMT) is an important therapeutic approach for the treatment of malignant diseases, opportunistic infection and graft-versus-host disease (GVHD), in which T cells included in grafts are involved, must be well controled. In this study, we examined T cell reconstitution after allo-BMT in terms of T cell-related antigen expression and T cell activation pathways. The expression of CD2, CD3, and CD8 bacame normal at 1 month, 3 month, and 6 month, respectively, post allo-BMT.However, recovery of CD4 expression was impaired more than 1 year, thus resulting in long-term low CD4/CD8 ratio. Among T cell activation pathways, the CD28 pathway, which is sensitive to glucocorticoid but resistant to cyclosporin, recovered within 3 months, suggesting an important role of this pathway in T cell activation involved in acute GVHD.The CD29 (VLA beta-chain) expression was significantly increased in cases with severe GVHD,which suggests an crucial role of adhesion molecules in development of GVHD.Clarification of T cell development and dysfunction post allo-BMT will provide a theoretical basis with therapeutic approach to GVHD.

  • Research Products

    (6 results)

All Other

All Publications (6 results)

  • [Publications] Kanji Sugita: "Phenotype and reconstitution ofimmunoregulatory T cell subsets after T cell depleted allogeneic and autologous bone marrow transplantation." Transplantation. 57. 1465-1473 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kanji Sugita: "Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantaion." J. Clin. Invest. 94. 481-488 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Jun Kameoka: "Differential CD26 mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantation." Blood. 85. 1132-1137 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sugita K,Soifer RJ,Murray C,Schlossman SF,Ritz J,Morimoto C.: "Phenotype and reconstitution of immunoregulatory T cell subsets after T cell depleted allogeneic and autologous bone marrow transplantation." transplantation. 57. 1465-1473 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sugita K,Nojima Y,Tachibana K,Soiffer RJ,Murray C,Schlossman SF,Ritz J,Morimoto C.: "Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantaion." J.Clin.Invest. 94. 481-488 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kameoka J,Sato T,Torimoto Y,Sugita K: "Soiffer RJ,Schlossman SF,Ritz J,Morimoto C.Differential CD26 mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantation." Blood. 85. 1132-1137 (1995)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-09  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi